This is a synthetic peptide designed for use in combination with anti-KIF2A antibody (Catalog #: ARP33901_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
KIF2A
(Kinesin Heavy Chain Member 2A (KIF2A))
Synonyme
HK2 Peptide, KIF2 Peptide, C530030B14Rik Peptide, Kif2 Peptide, Kns2 Peptide, M-kinesin Peptide, kif2-a Peptide, fj55b02 Peptide, wu:fj55b02 Peptide, kinesin family member 2A Peptide, kinesin heavy chain member 2A L homeolog Peptide, kinesin heavy chain member 2A Peptide, zgc:103670 Peptide, Kinesin-2 Peptide, KIF2A Peptide, Kif2a Peptide, kif2a.L Peptide, zgc:103670 Peptide, GL50803_17333 Peptide, GL50803_16456 Peptide
Hintergrund
KIF2A plus end-directed microtubule-dependent motor is required for normal brain development. KIF2A may regulate microtubule dynamics during axonal growth and has microtubule depolymerization activity. The protein is implicated in formation of bipolar mitotic spindles. Kinesins, such as KIF2, are microtubule-associated motor proteins. For background information on kinesins, see MIM 148760.[supplied by OMIM].